Publikationen in Zusammenarbeit mit Forschern von London School of Hygiene & Tropical Medicine (92)

2024

  1. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  2. Food biodiversity and gastrointestinal cancer risk in nine European countries: Analysis within a prospective cohort study

    European Journal of Cancer, Vol. 210

  3. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project

    Gut Microbes, Vol. 16, Núm. 1

  4. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

  5. Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 404-416

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: Comparison with sporadic primary progressive aphasia

    Brain Communications, Vol. 5, Núm. 2

  3. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

    European Urology, Vol. 84, Núm. 1, pp. 127-137

  4. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 593-606

  5. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592

  6. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

    Journal of Neurology, Vol. 270, Núm. 4, pp. 1976-1988

  7. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1466-1477

  8. Neuropsychiatric symptoms in genetic frontotemporal dementia: Developing a new module for Clinical Rating Scales

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 5, pp. 357-368

  9. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

    Journal of the Neurological Sciences, Vol. 451

  10. Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: Findings from the GENetic Frontotemporal dementia Initiative cohort

    Brain Communications, Vol. 5, Núm. 2

  11. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes

    Nature Communications, Vol. 14, Núm. 1

  12. Understanding public procurement within the health sector: a priority in a post-COVID-19 world

    Health economics, policy, and law, Vol. 18, Núm. 2, pp. 172-185

2022

  1. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  2. Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 93, Núm. 2, pp. 158-168

  3. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340